Liposomal Glutathione Powder 50%

Liposomal Glutathione (reduced); assay 50.0% by HPLC; phospholipid-encapsulated powder form; supported by representative batch LXLP260514.

Category: Brand:

Description

LIPOSOMAL DELIVERY INGREDIENT

Liposomal Glutathione (reduced) Powder

Liposomal Glutathione (reduced) is supplied as a phospholipid-encapsulated powder for formulators who need the active dispersed in a lipid bilayer rather than as a free crystalline solid. This grade is offered as a B2B raw material: 50% reduced glutathione of the active on a phospholipid carrier, produced by thin-film hydration followed by high-pressure homogenisation and spray drying. It is intended for further processing by the buyer (capsules, stick packs, sachets, liquid or powder blends). The material is characterised by phospholipid identity, particle-size distribution and encapsulation-related parameters rather than by crystallinity, so the specification below is written accordingly.

Off-white liposomal glutathione powder texture, soft agglomerated grain close-up

COA-Backed Specification

Ingredient system Liposomal Glutathione (reduced) (phospholipid bilayer encapsulation)
Form and colour Fine off-white powder
Assay 50.0%
Method HPLC
Particle size 98% through 80 mesh
Loss on drying <=5.0%
Ash <=5.0%
Heavy metals Within the limits of the approved specification
Microbiological limits Within the limits of the approved specification
Representative batch LXLP260514
Manufacture date 14 May 2026
Shelf life Two years when stored properly

Representative values do not replace the current shipment COA.

Off-white powder trail on a stainless collection pan in a drying room

Buyer Decision Guide

Liposomal grades are specified differently from plain powders. Buyers should agree on three things before approval: the carrier system (phosphatidylcholine from sunflower or soy lecithin, or a synthetic phospholipid), the declared active content of the encapsulated system, and the dispersion behaviour in the buyer’s own matrix. Confirm the intended final dosage form at enquiry stage.

  • Active content: 50% reduced glutathione on a phospholipid carrier, expressed on the encapsulated system rather than on total powder mass.
  • Carrier declaration: phosphatidylcholine source and phospholipid content are stated on the COA for identity control.
  • Particle size: micro-dispersible powder, specification agreed against the dispersion test the buyer will run.
  • Dispersion: designed to disperse in water and in oil-free aqueous matrices; evaluate in your own base before scale-up.
  • Handling: hygroscopic, sensitive to heat and oxygen; keep sealed, cool and dry, and open only under controlled conditions.
  • This material is a raw material for further processing, not a finished consumer product.
Off-white powder spread on a dark slate tile beside a stainless spatula

How This Grade Differs

Liposomal Glutathione (reduced) is not interchangeable with plain Glutathione (reduced) powder on a weight-for-weight basis. The active is held in a phospholipid bilayer, so the declared content refers to the encapsulated system, and the material behaves differently in dispersion, taste masking and flow. Buyers comparing quotations should normalise on the active content stated on the COA, not on the price per kilogram of powder.

Compare these related grades before approval:

For a substitution review, compare botanical identity, plant part, assay target, analytical method, physical form and the current offered-batch COA.

Application Areas

  • Hard capsules and two-piece capsule filling
  • Stick packs and single-serve sachets
  • Powder blends and dry mixes
  • Beverage and liquid concentrate systems, subject to the buyer’s process validation

Packaging and Delivery

  • Evaluation sample typically 10-20 g, subject to stock
  • Regular MOQ typically 1 kg
  • 1 kg foil bag or 25 kg fibre drum with inner food-grade liner
  • Custom packing and private-label options subject to confirmation
  • Typical lead time 7-15 working days after deposit

Quality and Documentation

Representative batch LXLP260514 supports the specification table above. Use the cited record for preliminary comparison and request the offered-lot COA for final technical approval. Batch COA, specification sheet, agreed third-party testing and export documents are available for buyer verification.

Frequently Asked Questions

What physical form does Liposomal Glutathione Powder 50% ship in?

Fine off-white powder, milled to 98% through 80 mesh.

What do you declare for moisture and ash?

Both are released against the limits on the approved specification; the measured result for your lot appears on its COA.

How long can we hold stock before use?

Two years when stored properly from the manufacture date when the pack stays sealed and dry.

What assay does Liposomal Glutathione Powder 50% carry on the certificate of analysis?

Assay 50.0%, determined by HPLC.

How is lot traceability handled?

Each lot keeps batch records and a retained sample, and the certificate for LXLP260514 carries the same batch reference used in the quotation.

What is the usual lead time?

Regular production normally takes 7-15 working days after deposit, depending on stock, volume, testing and customisation requirements.

Can I get a sample before placing the order?

Yes. An evaluation sample is normally available before a formal order. Sample quantity, courier account and destination are confirmed at the time of request.

Can you produce to our own specification or packing?

Alternative assay targets, particle size, packing and private-label requirements are reviewed case by case, subject to production feasibility and a revised written specification.

Request COA, Sample or Quotation

Send your target specification, application, order quantity, destination country and required test limits.

Get the current batch COA, a sample or a quotation